The male contraceptives market size has grown strongly in recent years. It will grow from $10.46 billion in 2025 to $11.25 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing awareness of family planning and reproductive healthcare, widespread use of condoms for pregnancy prevention and sexually transmitted infection protection, expansion of pharmaceutical research in reproductive hormone regulation, government-led population control and reproductive health programs, and rising emphasis on sexually transmitted disease prevention initiatives.
The male contraceptives market size is expected to see strong growth in the next few years. It will grow to $15.2 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period is driven by advancements in reversible male contraceptive technologies and implant systems, development of non-hormonal sperm inhibition approaches, increasing regulatory approvals for male contraceptive candidates, rising application of AI in drug discovery for reproductive health, and growing involvement of men in shared contraceptive decision-making. Key trends in the forecast period include increasing demand for non-hormonal male contraceptive solutions with improved safety and reversibility profiles, rising clinical trials focused on long-term efficacy of male birth control methods, growing adoption of advanced condom materials offering enhanced comfort and durability, expanding awareness of shared responsibility in contraception among men, and increased integration of telehealth platforms for reproductive health counseling and services.
The increasing awareness of male reproductive health is anticipated to drive the growth of the male contraceptives market going forward. Male reproductive health awareness refers to the growing understanding among men regarding fertility control, contraceptive options, and preventive reproductive healthcare. Awareness of male reproductive health is increasing due to the expansion of structured sexual education programs that deliver information about fertility, contraception, and preventive care, enabling men to better understand and take responsibility for reproductive health decisions. Awareness of male reproductive health supports the adoption of male contraceptives by encouraging men to understand fertility control options, assume greater responsibility in shared family planning decisions, and actively select preventive methods to avoid unintended pregnancies. For instance, in July 2025, according to the Local Government Association, a UK-based organization, more than 2.74 million individuals accessed sexual health clinics in England in 2023, with men accounting for over 60% of all new sexually transmitted infection (STI) diagnoses in the country. Therefore, the increasing awareness of male reproductive health is driving the growth of the male contraceptives market.
Leading companies operating in the male contraceptives market are focusing on developing innovative solutions, such as non-hormonal reversible vas-occlusive technologies to provide safe, effective, and reversible birth control options for men with minimal side effects. Non-hormonal reversible vas-occlusive technology is a male contraceptive method that temporarily blocks or seals the vas deferens (the tubes that carry sperm) without using hormones, and it helps by preventing sperm from being included in semen while allowing the effect to be reversible so fertility can be restored later. For example, in May 2023, Next Life Sciences, a US-based biotechnology company, launched Plan A, an innovative male birth control technology designed as a non-hormonal, reversible contraceptive solution that works through a minimally invasive procedure to place a biocompatible hydrogel-based material in the vas deferens. It creates a temporary barrier that blocks sperm transport while preserving normal hormone levels and sexual function, thereby offering an alternative to condoms and permanent vasectomy with the added benefit of potential reversibility as the material is designed to degrade or be removed over time to restore fertility.
In January 2023, the Male Contraceptive Initiative (MCI), a US-based nonprofit organization, partnered with Eppin Pharma to support advancement of clinical research and development for a novel non-hormonal male contraceptive. Through this investment, MCI and Eppin Pharma aim to accelerate development of a first-in-class non-hormonal contraceptive solution for men that targets sperm function rather than hormonal pathways, with the objective of delivering a safe, reversible, and effective alternative to existing contraceptive methods and addressing a significant unmet need in reproductive health. Eppin Pharma is a US-based biotechnology company focused on developing non-hormonal male contraceptive therapies that target sperm motility via the EPPIN protein pathway.
Major companies operating in the male contraceptives market are Bayer Aktiengesellschaft, Reckitt Benckiser Group plc, Church & Dwight Co. Inc., Mankind Pharma Limited, Okamoto Industries Inc., Karex Berhad, LifeStyles Healthcare Pte. Ltd., Fuji Latex Co. Ltd., HLL Lifecare Limited, Cupid Limited, Guilin Latex Factory Co. Ltd., Shanghai Mingbang Rubber Products Co. Ltd., Ritex GmbH, RFSU AB, Glyde Corporation Pty Ltd., Contraline Inc., NEXT Life Sciences Inc., YourChoice Therapeutics Inc., Eppin Pharma Inc.
North America was the dominant region in the male contraceptives market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in male contraceptives report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the male contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The male contraceptives market consists of sales of contraceptive pills, injectable formulations, transdermal gels, implants, intra-vas devices, spermicidal products, and other male-oriented fertility control products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The male contraceptives market research report is one of a series of new reports that provides male contraceptives market statistics, including male contraceptives industry global market size, regional shares, competitors with a male contraceptives market share, detailed male contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the male contraceptives industry. This male contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The male contraceptives market size is expected to see strong growth in the next few years. It will grow to $15.2 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period is driven by advancements in reversible male contraceptive technologies and implant systems, development of non-hormonal sperm inhibition approaches, increasing regulatory approvals for male contraceptive candidates, rising application of AI in drug discovery for reproductive health, and growing involvement of men in shared contraceptive decision-making. Key trends in the forecast period include increasing demand for non-hormonal male contraceptive solutions with improved safety and reversibility profiles, rising clinical trials focused on long-term efficacy of male birth control methods, growing adoption of advanced condom materials offering enhanced comfort and durability, expanding awareness of shared responsibility in contraception among men, and increased integration of telehealth platforms for reproductive health counseling and services.
The increasing awareness of male reproductive health is anticipated to drive the growth of the male contraceptives market going forward. Male reproductive health awareness refers to the growing understanding among men regarding fertility control, contraceptive options, and preventive reproductive healthcare. Awareness of male reproductive health is increasing due to the expansion of structured sexual education programs that deliver information about fertility, contraception, and preventive care, enabling men to better understand and take responsibility for reproductive health decisions. Awareness of male reproductive health supports the adoption of male contraceptives by encouraging men to understand fertility control options, assume greater responsibility in shared family planning decisions, and actively select preventive methods to avoid unintended pregnancies. For instance, in July 2025, according to the Local Government Association, a UK-based organization, more than 2.74 million individuals accessed sexual health clinics in England in 2023, with men accounting for over 60% of all new sexually transmitted infection (STI) diagnoses in the country. Therefore, the increasing awareness of male reproductive health is driving the growth of the male contraceptives market.
Leading companies operating in the male contraceptives market are focusing on developing innovative solutions, such as non-hormonal reversible vas-occlusive technologies to provide safe, effective, and reversible birth control options for men with minimal side effects. Non-hormonal reversible vas-occlusive technology is a male contraceptive method that temporarily blocks or seals the vas deferens (the tubes that carry sperm) without using hormones, and it helps by preventing sperm from being included in semen while allowing the effect to be reversible so fertility can be restored later. For example, in May 2023, Next Life Sciences, a US-based biotechnology company, launched Plan A, an innovative male birth control technology designed as a non-hormonal, reversible contraceptive solution that works through a minimally invasive procedure to place a biocompatible hydrogel-based material in the vas deferens. It creates a temporary barrier that blocks sperm transport while preserving normal hormone levels and sexual function, thereby offering an alternative to condoms and permanent vasectomy with the added benefit of potential reversibility as the material is designed to degrade or be removed over time to restore fertility.
In January 2023, the Male Contraceptive Initiative (MCI), a US-based nonprofit organization, partnered with Eppin Pharma to support advancement of clinical research and development for a novel non-hormonal male contraceptive. Through this investment, MCI and Eppin Pharma aim to accelerate development of a first-in-class non-hormonal contraceptive solution for men that targets sperm function rather than hormonal pathways, with the objective of delivering a safe, reversible, and effective alternative to existing contraceptive methods and addressing a significant unmet need in reproductive health. Eppin Pharma is a US-based biotechnology company focused on developing non-hormonal male contraceptive therapies that target sperm motility via the EPPIN protein pathway.
Major companies operating in the male contraceptives market are Bayer Aktiengesellschaft, Reckitt Benckiser Group plc, Church & Dwight Co. Inc., Mankind Pharma Limited, Okamoto Industries Inc., Karex Berhad, LifeStyles Healthcare Pte. Ltd., Fuji Latex Co. Ltd., HLL Lifecare Limited, Cupid Limited, Guilin Latex Factory Co. Ltd., Shanghai Mingbang Rubber Products Co. Ltd., Ritex GmbH, RFSU AB, Glyde Corporation Pty Ltd., Contraline Inc., NEXT Life Sciences Inc., YourChoice Therapeutics Inc., Eppin Pharma Inc.
North America was the dominant region in the male contraceptives market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in male contraceptives report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the male contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The male contraceptives market consists of sales of contraceptive pills, injectable formulations, transdermal gels, implants, intra-vas devices, spermicidal products, and other male-oriented fertility control products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The male contraceptives market research report is one of a series of new reports that provides male contraceptives market statistics, including male contraceptives industry global market size, regional shares, competitors with a male contraceptives market share, detailed male contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the male contraceptives industry. This male contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Male Contraceptives Market Characteristics
3. Male Contraceptives Market Supply Chain Analysis
4. Global Male Contraceptives Market Trends And Strategies
5. Male Contraceptives Market Analysis Of End Use Industries
7. Global Male Contraceptives Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Male Contraceptives Total Addressable Market (TAM) Analysis for the Market
9. Male Contraceptives Market Segmentation
10. Male Contraceptives Market Regional And Country Analysis
11. Asia-Pacific Male Contraceptives Market
12. China Male Contraceptives Market
13. India Male Contraceptives Market
14. Japan Male Contraceptives Market
15. Australia Male Contraceptives Market
16. Indonesia Male Contraceptives Market
17. South Korea Male Contraceptives Market
18. Taiwan Male Contraceptives Market
19. South East Asia Male Contraceptives Market
20. Western Europe Male Contraceptives Market
21. UK Male Contraceptives Market
22. Germany Male Contraceptives Market
23. France Male Contraceptives Market
24. Italy Male Contraceptives Market
25. Spain Male Contraceptives Market
26. Eastern Europe Male Contraceptives Market
27. Russia Male Contraceptives Market
28. North America Male Contraceptives Market
29. USA Male Contraceptives Market
30. Canada Male Contraceptives Market
31. South America Male Contraceptives Market
32. Brazil Male Contraceptives Market
33. Middle East Male Contraceptives Market
34. Africa Male Contraceptives Market
36. Male Contraceptives Market Competitive Landscape And Company Profiles
37. Male Contraceptives Market Other Major And Innovative Companies
41. Male Contraceptives Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Male Contraceptives Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses male contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for male contraceptives? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The male contraceptives market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Hormonal Methods; Non Hormonal Methods; Barrier Devices; Reversible Inhibitors; Other Product Types2) By Administration Route: Oral; Injectable; Topical Or Transdermal; Surgical; Implantable
3) By End User: Hospitals; Homecare; Clinics; Other End Users
Subsegments:
1) By Hormonal Methods: Testosterone Based Pills; Hormonal Injections; Hormonal Gels; Hormonal Implants; Combination Hormone Therapies2) By Non Hormonal Methods: Sperm Motility Inhibitors; Protein Targeting Agents; Retinoic Acid Inhibitors
3) By Barrier Devices: Latex Condoms; Non Latex Condoms; Polyurethane Condoms; Polyisoprene Condoms; Textured Condoms
4) By Reversible Inhibitors: Reversible Vas Deferens Blockers; Hydrogel Based Inhibitors; Sperm Transport Blocking Devices
5) By Other Product Types: Experimental Fertility Control Products; Combination Contraceptive Products; Reproductive Health Supplements
Companies Mentioned: Bayer Aktiengesellschaft; Reckitt Benckiser Group plc; Church & Dwight Co. Inc.; Mankind Pharma Limited; Okamoto Industries Inc.; Karex Berhad; LifeStyles Healthcare Pte. Ltd.; Fuji Latex Co. Ltd.; HLL Lifecare Limited; Cupid Limited; Guilin Latex Factory Co. Ltd.; Shanghai Mingbang Rubber Products Co. Ltd.; Ritex GmbH; RFSU AB; Glyde Corporation Pty Ltd.; Contraline Inc.; NEXT Life Sciences Inc.; YourChoice Therapeutics Inc.; Eppin Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Bayer Aktiengesellschaft
- Reckitt Benckiser Group plc
- Church & Dwight Co. Inc.
- Mankind Pharma Limited
- Okamoto Industries Inc.
- Karex Berhad
- LifeStyles Healthcare Pte. Ltd.
- Fuji Latex Co. Ltd.
- HLL Lifecare Limited
- Cupid Limited
- Guilin Latex Factory Co. Ltd.
- Shanghai Mingbang Rubber Products Co. Ltd.
- Ritex GmbH
- RFSU AB
- Glyde Corporation Pty Ltd.
- Contraline Inc.
- NEXT Life Sciences Inc.
- YourChoice Therapeutics Inc.
- Eppin Pharma Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.25 Billion |
| Forecasted Market Value ( USD | $ 15.2 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
